Topical Wound Agents Market To Reach $2.84 Billion By 2030

Topical Wound Agents Market Growth & Trends

The global topical wound agents market size is estimated to reach USD 2.84 billion by 2030, registering to grow at a CAGR of 7.74% from 2025 to 2030 according to a new report by Grand View Research, Inc. The rising prevalence of chronic injuries, growing number of surgical procedures, launch of technologically advanced products, and increasing cases of burns globally are the key driving factors for the market.

Topical wound agents generally provide adequate moisture to the bruise and allow autolytic debridement. The increasing prevalence of chronic injuries and rising number of surgical procedures are the key driving factors for market growth. For instance, as per a report published by the ScienceDirect in 2018, surgical infection has highest prevalence rate of around 4.0%, followed by diabetic foot ulcers which are around 3.4%. In addition, rising number of medical facilities for treating unhealed bruises across the globe is also expected to surge market growth over the forecast period. In May 2019, Dalvkot Wound Care (DWC) established the first medical facility for treating bruises in Bangalore, India, which aims to provide remedies to chronic injuries. Thus, such developments may boost the demand for topical wound agents, as they are specifically used for such conditions. Furthermore, new product launches by key players may also positively impact market growth. For instance, Arch Therapeutics, Inc., launched AC5 Topical Gel, which got its FDA approval in October 2019. This gel allows rapid injury healing with minimal risk of getting further complications. Therefore, such factors are anticipated to propel growth of the market over the forecast period.

 Request a free sample copy or view report summary: Topical Wound Agents Market Report

Topical Wound Agents Market Report Highlights

• The creams segment held the largest market share, 42.15%, in 2024 and is expected to grow fastest during the forecast period.

• The acute wounds segment held the largest share in 2024. This segment includes surgical & traumatic wounds and burns.

• The hospitals segment held the largest share of 46.34% in 2024 and it is anticipated to witness the fastest growth in the coming years.

Topical Wound Agents Market Segmentation

Grand View Research has segmented the global topical wound agents market based on product, application, end-use, and region:

Topical Wound Agents Product Outlook (Revenue, USD Million, 2018 - 2030)

• Creams

• Gels

• Sprays

• Others

Topical Wound Agents Application Outlook (Revenue, USD Million, 2018 - 2030)

• Chronic Wounds

  • Diabetic Foot Ulcers

  • Pressure Ulcers

  • Venous Leg Ulcers

  • Others

• Acute Wounds

  • Surgical & Traumatic Wounds

  • Burns

Topical Wound Agents End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Clinics

• Others

Topical Wound Agents Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in Topical Wound Agents Market

• Smith+Nephew

• Mölnlycke Health Care AB

• Teva Pharmaceutical Industries Ltd

• Arch Therapeutics, Inc.

• Viatris Inc

• Ipca Laboratories Ltd.

• Chiesi USA

• SERDA Therapeutics